2,600 results match your criteria: "Late Effects of Childhood Cancer and Treatment"

Background: The purpose of the present systematic review and meta-analyses was to appraise the case-control studies that have evaluated late adverse effects of chemotherapy for treating hematological malignancies in pediatric patients.

Methods: Five electronic databases along with grey literature were searched using broad keywords and MeSH terms for the articles that could meet the eligibility criteria. The Newcastle-Ottawa Scale was employed for quality assessment.

View Article and Find Full Text PDF

Background: Childhood cancer survivors (CCS) are at risk for medical and psychosocial late effects of their disease and its treatment and are recommended to receive annual follow-ups. Yet, rates of follow-up adherence are suboptimal and may be influenced by the organization and delivery of their healthcare. This research aimed to examine experts' perceptions of facilitators and barriers to healthcare organization and delivery to CCS.

View Article and Find Full Text PDF

Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivors.

Cancer Epidemiol

December 2024

INSERM, U900, Institut Curie, PSL Research University, Saint-Cloud, France; Conservatoire National des Arts et Métiers, Paris, France.

Article Synopsis
  • Identifying key risk factors in childhood cancer survivors is crucial for improving treatment and follow-up care to reduce long-term mortality.
  • A study of 7,670 childhood cancer survivors revealed that subsequent cancers, severe heart conditions, and radiotherapy significantly impact Life Years Lost.
  • Radiotherapy was identified as a major cause of early death, highlighting the need for ongoing monitoring of patients who develop additional health issues post-treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Advances in cancer treatment have led to more cancer survivors, increasing the incidence of both adult and childhood cancer survivors.
  • However, survivors treated with certain therapies, like anthracyclines and radiation, face a heightened risk of long-term cardiovascular issues, including heart failure and coronary artery diseases.
  • It’s crucial to assess cardiovascular risk after cancer therapy and implement long-term monitoring and preventive strategies in alignment with current guidelines to manage potential late complications.
View Article and Find Full Text PDF

Late Effects After Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi Anemia.

Turk J Haematol

November 2024

Division of Pediatric Hematology and Bone Marrow Transplantation Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Article Synopsis
  • Fanconi anemia (FA) is a genetic condition leading to bone marrow failure, and while hematopoietic stem cell transplantation (HSCT) can provide long-term survival, patients face ongoing health challenges after treatment.
  • A study of 36 FA patients who had undergone HSCT showed significant long-term issues, including hormonal imbalances, growth impairments, and signs of metabolic syndrome, highlighting the need for better follow-up care guidelines.
  • Key findings included gonadal dysfunction in 35% of patients, pulmonary function issues in nearly half, and a small percentage developing secondary cancers, emphasizing the importance of addressing late effects of HSCT in FA survivors.
View Article and Find Full Text PDF

Childhood cancer survivors' (CCS) knowledge about late effects can promote positive health behaviors and autonomy. Cardiotoxicity is a major source of morbidity, which can be mitigated through exercise. Descriptive and Fisher's exact statistics were used to characterize health knowledge and physical activity in CCS ≥13 years at high risk for cardiotoxicity.

View Article and Find Full Text PDF

Background: Childhood cancer survivors face high risks of adverse late health effects. Long-term follow-up care for childhood cancer survivors is crucial to improve their health and quality of life. However, implementation remains a challenge.

View Article and Find Full Text PDF

Acute lymphoblastic leukemia (ALL) constitutes approximately 25% of pediatric cancers, and with contemporary protocols, the 5-year survival rate is over 90%. Despite improved survival, neurocognitive impairments from treatment raise concerns. This registry study aimed to explore the impact of ALL treatment on educational outcomes from school year nine in Swedish children.

View Article and Find Full Text PDF

Accessibility of and Barriers to Long-Term Follow-Up Care for Childhood Cancer Survivors.

JAMA Netw Open

October 2024

School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

Importance: Childhood cancer survivorship programs and long-term follow-up (LTFU) practices are inadequate in most regions of China.

Objective: To understand the clinician and caregiver perceptions of LTFU care and to identify barriers to adherence to LTFU care in mainland China.

Design, Setting, And Participants: This survey study had a 2-phase sequential mixed-methods approach, consisting of a cross-sectional survey followed by semistructured interviews.

View Article and Find Full Text PDF

The benefit of long-term methylphenidate in childhood brain injury survivorship: A review.

Appl Neuropsychol Child

October 2024

Clinical Health Psychology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

Article Synopsis
  • * A systematic review analyzed 1926 studies, focusing on six that evaluated the impact of methylphenidate on neuropsychological outcomes in children with ABI, particularly those with brain tumors, leukemia, and epilepsy.
  • * Findings suggest that methylphenidate results in lasting improvements in attention, processing speed, social skills, and quality of life, with mild and temporary side effects.
View Article and Find Full Text PDF

Long-term quality of survival after pediatric low-grade glioma.

Childs Nerv Syst

October 2024

Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS, Utrecht, Netherlands.

Background: Low-grade glioma is the most common brain tumor in children with different modes of treatment and a high overall survival. Low-grade glioma is considered a chronic disease, since residual tumor is present in many children. The tumor and its treatment lead to acquired brain injury with diverse consequences for later life based on factors like the diverse tumor locations, treatment(s) applied, neurofibromatosis type 1, and age at diagnosis.

View Article and Find Full Text PDF

Safety of Prior Propranolol Therapy for Infantile Hemangioma.

Pediatr Dermatol

November 2024

Department of Dermatology, West Virginia University, Morgantown, West Virginia, USA.

Article Synopsis
  • * A study using the TrinetX database looked at children aged 10-17 who received propranolol for IH and assessed risks of growth impairment, sleep disorders, learning disabilities, and diabetes mellitus.
  • * The results indicated no significant long-term risks for these adverse effects in children treated with propranolol for IH during infancy, supporting the medication's safety.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied how surviving childhood leukemia (ALL) might affect mental health as kids grow up.
  • They looked at almost 2,000 survivors and compared them to their siblings and other kids to see who had more psychiatric problems by age 30.
  • They found that survivors had a slightly higher chance of mental health issues, especially those who had serious treatments, but overall, the risks were similar to their siblings and friends.
View Article and Find Full Text PDF

Introduction: Childhood cancer survivors (CCS) are at risk of experiencing psychological distress years after completing cancer treatments. We aimed to assess the prevalence and associated risk factors affecting psychological distress and health-related quality of life (HRQOL) among CCS in Singapore, and compare with their siblings without a history of or existing cancer as control.

Method: We recruited 143 young adult CCS aged ≥18 years attending survivorship clinics at KK Women's and Children's Hospital in Singapore who were in remission for ≥5 years and treatment-free for ≥2 years, and 57 siblings.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the late effects and quality of life in pediatric survivors of mature B-non-Hodgkin lymphoma (NHL) after receiving treatment.
  • It included 273 patients treated at Children's Cancer Hospital of Egypt, with assessments for various toxicities and quality of life conducted over at least five years.
  • Results showed notable pulmonary dysfunction in 58.6% of patients, some cognitive impairments, and overall satisfactory quality of life scores, but with significant issues in the physical domain for certain groups, specifically linked to pulmonary dysfunction and older age at diagnosis.
View Article and Find Full Text PDF

Late effects surveillance adherence among young adult childhood cancer survivors: A population-based study.

Pediatr Blood Cancer

December 2024

Departments of Pediatrics, Medicine, and Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Lifelong, guideline-based monitoring for late effects is recommended for childhood cancer survivors (CCS). We examined rates of receiving surveillance tests among at-risk young adult CCS in a population-based study (n = 253; 50% Hispanic/Latino; mean post-treatment interval 14.5 years, range: 5-22).

View Article and Find Full Text PDF

Purpose: In childhood cancer survivors (CCS), high physical activity (PA) and low sedentary time may reduce risks of late-effects. PA behaviors and screen time, and how they relate to moderate-to-vigorous PA (MVPA) in CCS, are largely unknown. We examined PA behaviors and screen time, and their cross-sectional associations with MVPA.

View Article and Find Full Text PDF

Purpose: Childhood Cancer Survivors (CCSs) have an increased risk for treatment-related chronic health conditions, but the adherence to long-term follow-up (LTFU) care decreases over time. We therefore assessed the CCSs' development of cancer knowledge, cancer worries, self-management skills, and expectations for LTFU care in a structured, cancer center-based transition model-a crucial part for maintaining adherence.

Methods: Using questionnaire-based surveys, we compared the CCSs' cancer knowledge with medical record data and assessed cancer worries (6 questions), self-management skills (15 questions), and expectations (12 questions) longitudinally by validated scales.

View Article and Find Full Text PDF

Study Question: What is the impact of the EuroNet-PHL-C2 treatment for boys with classical Hodgkin lymphoma (cHL) on semen parameters?

Summary Answer: More than half of the patients (52%, n = 16/31) had oligozoospermia or azoospermia at 2 years from cHL diagnosis; particularly boys treated for advanced-stage cHL had low sperm counts and motility.

What Is Known Already: Chemotherapy and radiotherapy to the inguinal region or testes can impair spermatogenesis and result in reduced fertility. The EuroNet-PHL-C2 trial aims to minimize radiotherapy in standard childhood cHL treatment, by intensifying chemotherapy.

View Article and Find Full Text PDF

Context: In recent studies of childhood cancer survivors, diabetes has been considered a late effect associated with high therapeutic doses of radiation therapy. Our recent study of atomic bomb (A-bomb) survivors also suggested an association between radiation dose and diabetes incidence, with exposure city and age at exposure as radiation dose effect modifiers. Insulin resistance mediated by systemic inflammation and abnormal body composition has been suggested as a possible primary mechanism for the incidence of diabetes after total body irradiation, however, no studies have examined low-to- moderate radiation exposure (<4 Gy) and insulin resistance in A-bomb survivors.

View Article and Find Full Text PDF